Mindfulness-based cognitive therapy (MBCT) and mindfulness-integrated cognitive behavior therapy (MiCBT) differ in their origins, structure, and evidence. MBCT was developed to prevent depressive relapse and has strong support from systematic reviews and meta-analyses, earning endorsement in clinical guidelines, but its single-disorder focus may limit its use in diverse health settings. MiCBT was designed for transdiagnostic applications, incorporating exposure procedures and compassion training to reduce avoidance, and shows promising early evidence, though it lacks inclusion in clinical guidelines. More high-quality randomized controlled trials and systematic reviews are needed for MiCBT, while MBCT requires greater attention to dissemination and implementation research.
In a pilot trial, 31 adults with PTSD received either real or sham repetitive transcranial magnetic stimulation (rTMS) over the right dorsolateral prefrontal cortex. Mindfulness scores, measured by the Five Facet Mindfulness Questionnaire, did not improve significantly immediately after treatment when corrected for multiple comparisons. However, by three months after treatment, those who received real rTMS showed significant gains in total mindfulness and nonreactivity. The delayed improvement suggests the benefits of rTMS on dispositional mindfulness may take time to emerge. The findings indicate that brain stimulation might eventually help reduce PTSD-related suffering by boosting mindfulness.